CU Medical Systems KRX:115480KOSDAQ
씨유메디칼 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, CU Medical Systems reported revenue of ₩21.2bn, up 70.6% year on year, and operating profit of ₩5.9bn. CU Medical Systems (씨유메디칼) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Profit +50% Revenue +30% Revenue & profit growth Op. margin 20%+ Screener
CU Medical Systems quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩21.2bn | +70.6% | ₩5.9bn | ₩6.7bn |
| Q1 2026 | ₩15.3bn | +73.1% | ₩2.5bn | ₩2.8bn |
| Q4 2025 derived | ₩15.7bn | +28.0% | ₩4.1bn | −₩2.4bn |
| Q3 2025 | ₩11.3bn | +54.9% | ₩2.4bn | ₩1.9bn |
| Q2 2025 | ₩12.4bn | +23.4% | ₩3.2bn | ₩599m |
| Q1 2025 | ₩8.8bn | -19.9% | ₩1.1bn | ₩628m |
| Q4 2024 derived | ₩12.3bn | +28.0% | ₩3.0bn | −₩4.8bn |
| Q3 2024 | ₩7.3bn | -16.0% | ₩550m | −₩404m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
CU Medical Systems top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest CU Medical Systems news Korean headlines
No articles yet.